# US 6,726,727 B2 · Cross-linked ultra-high molecular weight polyethylene for medical implant use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,726,727 B2
- Document ID: US6726727B2
- Status: Granted
- Kind: B2
- Application number: 10/272,067
- Filed: 2002-10-16
- Published: 2003-07-10
- Granted: 2004-04-27
- Earliest claimed: 2001-02-23
- Assignees: Smith & Nephew, Inc.
- Inventors: Marcus L. Scott; Shilesh C. Jani
- Web page: https://patentgrep.com/patent/US6726727B2

## CPC

- A61L 27/50: Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials}
- A61L 27/16: obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C08L 23/06: Polyethylene
- C08L 2312/06: by radiation
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The present invention relates to the prevention and decrease of osteolysis produced by wear of the ultrahigh molecular weight polyethylene (UHMWPE). Methods are disclosed for the isolation of wear particles, preparation of implants exhibiting decreased wear in comparison to conventional UHMWPE and preparation of implants that cause decreased biological response in comparison to conventional UHMWPE. The implants created by these methods are also included in the present invention.

## Claims

### Claim 1

A method of producing an UHMWPE medical implant for use in a body comprising the steps of:
crosslinking the UHMWPE;
annealing the UHMWPE;
machining the UHMWPE to form said implant;
wear testing the implant;
analyzing wear particles created by said step of wear testing, said step of analyzing having sufficient sensitivity to detect particles having sizes of 0.05 μm or less;
determining the number of particulate debris; and
selecting a crosslinking irradiation dose that exhibits the lowest number of particulate debris relative to that exhibited by non-crosslinked UHMWPE treated by all of the above steps except said crosslinking step and said selecting step, and wherein the wear particles are decreased to a particle number of less than that exhibited by non-crosslinked UHMWPE treated by all of the above steps except said crosslinking step and said selecting step.

### Claim 2 (depends on 1)

The method of claim 1, wherein the crosslinking is performed using electromagnetic radiation, energetic subatomic particles, gamma radiation, e-beam radiation, x-ray radiation, or chemical crosslinking.

### Claim 3 (depends on 1)

The method of claim 1, wherein said crosslinking is performed using gamma radiation.

### Claim 4 (depends on 1)

The method of claim 1, wherein said crosslinking is at a dose of greater than five but less than or equal to fifteen MegaRad (MRad).

### Claim 5 (depends on 1)

The method of claim 1, wherein said crosslinking is at a dose of greater than five but less than or equal to ten MegaRad (MRad).

### Claim 6 (depends on 1)

The method of claim 1, wherein said annealing is performed below or equal to about 150° C.

### Claim 7 (depends on 1)

The method of claim 1, wherein said annealing is performed below about 150° C. and above about 140° C.

### Claim 8 (depends on 1)

The method of claim 1, wherein said annealing is performed at about 147° C.

### Claim 9 (depends on 1)

The method of claim 1, wherein said implant has a polymeric structure with a trans-vinylene index of greater than or equal to 0.10.

### Claim 10 (depends on 1)

The method of claim 1, wherein said implant has a polymeric structure with a trans-vinylene index of greater than about 0.15 and less than about 0.20.

### Claim 11 (depends on 1)

The method of claim 1, wherein said implant has a polymeric structure with greater than about 300 angstrom lamellar thickness.

### Claim 12 (depends on 1)

The method of claim 1, wherein said wear testing occurs on a joint simulator.

### Claim 13 (depends on 12)

The method of claim 12, wherein said joint simulator simulates the hip joint or the knee joint of a human.

### Claim 14 (depends on 1)

The method of claim 1, wherein said step of analyzing comprises analyzing with a scanning electron microscope.

### Claim 15 (depends on 1)

The method of claim 1 wherein said step of analyzing comprises analyzing with a Fourier Transform Infrared Spectrometer.

### Claim 16 (depends on 1)

The method of claim 1 wherein said step of analyzing comprises analyzing with an automated particle size analyzer.

### Claim 17

A method of producing an UHMWPE medical implant for use in a body comprising the steps of:
crosslinking the UHMWPE;
annealing the UHMWPE;
machining the UHMWPE to form said implant;
wear testing the implant;
analyzing wear particles created by said step of wear testing, said step of analyzing having sufficient sensitivity to detect particles having sizes of less than 0.2 μm;
determining the number of particulate debris; and
selecting a crosslinking irradiation dose that exhibits the lowest number of particulate debris relative to that exhibited by non-crosslinked UHMWPE treated by all of the above steps except said crosslinking step and said selecting step, and wherein the wear particles are decreased to a particle number of less than that exhibited by non-crosslinked UHMWPE treated by all of the above steps except said crosslinking step and said selecting step.
